Trial Profile
BPX-701 for the treatment of metastatic uveal melanoma
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 17 Mar 2016
Price :
$35
*
At a glance
- Drugs BPX 701 (Primary)
- Indications Uveal melanoma
- Focus Adverse reactions; Therapeutic Use
- 17 Mar 2016 New trial record